pdufa date for tirzepatide Today we shared that the U.S. FDA has accepted our Biologics License Application (BLA) an investigational gene therapy for Glycogen Storage Disease Type Ia (GSDIa) for priority review. This milestone means 9 Potential Blockbuster Drugs to

Any same price at every dose promotion expires within 24 hours of any price updates

Apply retinoid at night, GHK-Cu serum in the morning or on non-retinoid nights

Loose motions, or diarrhoea, showed up a bit more often with Mounjaro

10.1038/s12276-022-00739-7 18 HuJ.LiuW.ZouY.JiaoC.ZhuJ.XuQ.et al (2024)

SIM refers to clinically diagnosed weakness in critically ill patients that cannot be attributed to non-critical illness causes, with an incidence rate as high as 40% among critically ill patients in the ICU (8,12)

Concentrations are stronger, and professional oversight becomes essential to ensure safety and efficacy